Fed. Circ. Undoes Breckenridge Generic Laxative Patent Win
The Federal Circuit ruled Friday that Breckenridge Pharmaceutical Inc.'s planned generic version of the laxative drug Suprep infringes a patent owned by Braintree Laboratories Inc., reversing a New York federal judge's...To view the full article, register now.
Already a subscriber? Click here to view full article